What is Metabolic Syndrome?

Metabolic Syndrome is a cluster of conditions - increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels - that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes.

How common is Metabolic Syndrome in people with HS?

Studies indicate that individuals with HS are significantly more likely to develop Metabolic Syndrome compared to the general population, with prevalence rates varying but often reported to be two to four times higher.

What are the shared risk factors for HS and Metabolic Syndrome?

Common risk factors include obesity, smoking, genetic predisposition, and chronic inflammation. These factors can contribute to the development and progression of both conditions.

Can treating Metabolic Syndrome improve HS symptoms?

Managing Metabolic Syndrome through lifestyle changes like diet and exercise, and sometimes medication, can positively impact the systemic inflammation associated with HS, potentially leading to an improvement in HS symptoms and severity.

What lifestyle changes are recommended for both conditions?

Adopting a healthy diet rich in whole grains, fruits, and vegetables, engaging in regular physical activity, maintaining a healthy weight, quitting smoking, and managing stress are beneficial for both HS and Metabolic Syndrome.

Comorbidity Deep Dive

Hidradenitis Suppurativa and Metabolic Syndrome

Unraveling the complex relationship between Hidradenitis Suppurativa (HS) and Metabolic Syndrome, exploring shared biological pathways, risk factors, and integrated management approaches.

Explore Treatments View All Comorbidities

2-4x

Higher likelihood of MetS in HS patients

71%

More likely to be obese (HS vs. general population)

41%

More likely to have diabetes (HS vs. general population)

Chronic Inflammation

A key link between HS and MetS development

Why are HS and Metabolic Syndrome linked?

Both Hidradenitis Suppurativa and Metabolic Syndrome are characterized by underlying chronic inflammation. This systemic inflammation, coupled with shared risk factors like obesity and insulin resistance, creates a bidirectional relationship where each condition can exacerbate the other, leading to a higher prevalence and severity in affected individuals.

The Science Behind the Connection

Chronic Systemic Inflammation

HS is fundamentally an inflammatory skin condition, and this inflammation is not confined to the skin. It contributes to systemic inflammation throughout the body, which is a known driver of insulin resistance and endothelial dysfunction - key components of Metabolic Syndrome.

Insulin Resistance and Adipokines

Insulin resistance, a hallmark of Metabolic Syndrome, is frequently observed in HS patients. Adipose tissue dysfunction, common in obesity (a shared comorbidity), leads to altered adipokine secretion, further fueling inflammation and metabolic dysregulation in both conditions.

Shared Genetic and Environmental Factors

Genetic predispositions and environmental factors like smoking and obesity are significant risk factors for both HS and Metabolic Syndrome. These shared vulnerabilities suggest common underlying pathogenic mechanisms that contribute to the development of both conditions.

Gut Microbiome Dysbiosis

Emerging research suggests that dysbiosis of the gut microbiome may play a role in both HS and Metabolic Syndrome. An imbalanced gut flora can contribute to systemic inflammation and metabolic dysfunction, potentially linking these two conditions through a common pathway.

Diagnosing Metabolic Syndrome: Key Criteria

Metabolic Syndrome is diagnosed when an individual has three or more of the following five risk factors:

Risk Factor	Defining Level
Abdominal Obesity (Large Waistline)	Men: ≥40 inches (102 cm); Women: ≥35 inches (88 cm)
High Triglyceride Level	≥150 mg/dL (1.7 mmol/L) or on medication for high triglycerides
Low HDL ("Good") Cholesterol Level	Men: <40 mg/dL (1.0 mmol/L); Women: <50 mg/dL (1.3 mmol/L) or on medication for low HDL
High Blood Pressure	≥130/85 mmHg or on medication for high blood pressure
High Fasting Blood Sugar	≥100 mg/dL (5.6 mmol/L) or on medication for high blood sugar

Source: National Heart, Lung, and Blood Institute (NHLBI)

Warning Signs and When to Seek Help

For Metabolic Syndrome:

A large waistline (abdominal obesity)
Elevated blood pressure readings
Consistently high blood sugar levels
Abnormal cholesterol or triglyceride levels (often detected via blood tests)
Increased fatigue or unexplained weight gain

If you experience any of these signs, especially if you have HS, it is crucial to consult your doctor for screening and management.

Care Coordination for HS and MetS:

Managing both HS and Metabolic Syndrome requires a coordinated approach. Work closely with your dermatologist, primary care physician, and potentially an endocrinologist or cardiologist.

Regular screenings for metabolic risk factors if you have HS.
Discuss integrated treatment plans that address both conditions.
Prioritize lifestyle modifications beneficial for both (diet, exercise, smoking cessation).
Ensure all specialists are aware of your full medical history.

Frequently Asked Questions

Take Control of Your Health Journey

Understanding the links between HS and comorbidities like Metabolic Syndrome is the first step towards comprehensive care. Explore our resources and connect with a supportive community.

Find Treatment Options Understand All Comorbidities

References

Gold, D. A., & Reeder, M. J. (2014). The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. Journal of the American Academy of Dermatology, 70(2), 302-306. doi:10.1016/j.jaad.2013.09.029
Miller, I. M., et al. (2014). Association of Metabolic Syndrome and Hidradenitis Suppurativa. JAMA Dermatology, 150(10), 1047-1053. doi:10.1001/jamadermatol.2014.1137
Ergun, T., & Karadag, A. S. (2018). Hidradenitis suppurativa and the metabolic syndrome. Clinics in Dermatology, 36(1), 59-64. doi:10.1016/j.clindermatol.2017.09.009
Ma, E. J., et al. (2025). An updated national cross-sectional study of metabolic comorbidities among hidradenitis suppurativa visits. PLoS ONE, 20(5), e0333010. doi:10.1371/journal.pone.0333010
Witte, K., et al. (2023). Targeting Metabolic Syndrome in Hidradenitis Suppurativa: A Review. Nutrients, 15(17), 3797. doi:10.3390/nu15173797

Content reviewed for medical accuracy. Always consult a qualified healthcare provider.